Company news and developments, with original sources and dates.
Updated from source·Oct 18, 2026, 08:31 UTC
On 2026/10/8, AIPressRoom reported that Multiply Labs raised USD 75 million in Series B funding, led by Patrick Soon-Shiong and NantWorks. It uses robotic systems to automate biologic drug production, improving pharmaceutical manufacturing efficiency and quality consistency.